Alnylam Pharmaceuticals
ALNY
#555
Rank
S$54.36 B
Marketcap
S$409.91
Share price
-3.01%
Change (1 day)
15.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company